Llwytho...
Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer
Advances in the immunotherapy of cancer have prolonged survival for cancer patients, but the clinical and financial impact of treatments must be considered in determining the overall clinical utility and economic value of therapeutic agents. Quality-adjusted life years and incremental cost-effective...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Immunother Cancer |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6724271/ https://ncbi.nlm.nih.gov/pubmed/31481112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0707-9 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|